These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 7948743)
1. Neurochemical basis of interleukin 2-modified discrimination behaviour. Ho BT; Lu JG; Huo YY; Fan SH; Meyers CA; Tansey LW; Payne R; Levin VA Cytokine; 1994 Jul; 6(4):365-7. PubMed ID: 7948743 [TBL] [Abstract][Full Text] [Related]
2. The opioid mechanism of interferon-alpha action. Ho BT; Lu JG; Huo YY; Fan SH; Meyers CA; Tansey LW; Payne R; Levin VA Anticancer Drugs; 1994 Feb; 5(1):90-4. PubMed ID: 8186436 [TBL] [Abstract][Full Text] [Related]
3. Opioid-dopaminergic mechanisms in the potentiation of d-amphetamine discrimination by interferon-alpha. Ho BT; Huo YY; Lu JG; Tansey LW; Levin VA Pharmacol Biochem Behav; 1992 May; 42(1):57-60. PubMed ID: 1528947 [TBL] [Abstract][Full Text] [Related]
4. Discriminative stimulus effects of N-allylnormetazocine in rats trained to discriminate a kappa from a sigma agonist. Slifer BL; Dykstra LA Life Sci; 1987 Jan; 40(4):343-9. PubMed ID: 3027481 [TBL] [Abstract][Full Text] [Related]
5. Mu-opioid component of the ethylketocyclazocine (EKC) discriminative stimulus in the rat. Locke KW; Gorney B; Cornfeldt M; Fielding S Psychopharmacology (Berl); 1989; 99(4):492-6. PubMed ID: 2556726 [TBL] [Abstract][Full Text] [Related]
6. Effects of a kappa receptor agonist, ethylketocyclazocine, on water consumption in water-deprived and nondeprived rats in diurnal and nocturnal tests. Turkish S; Cooper SJ Pharmacol Biochem Behav; 1984 Jul; 21(1):47-51. PubMed ID: 6087378 [TBL] [Abstract][Full Text] [Related]
7. Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum. Schoffelmeer AN; Hogenboom F; Mulder AH Br J Pharmacol; 1997 Oct; 122(3):520-4. PubMed ID: 9351509 [TBL] [Abstract][Full Text] [Related]
8. [Evaluation of the discriminative stimulus effect of an enkephalin analog, EK-399, in the rat]. Nishida N; Yasuhara Y; Chiba S Nihon Yakurigaku Zasshi; 1991 Jun; 97(6):361-9. PubMed ID: 1651892 [TBL] [Abstract][Full Text] [Related]
9. Effects of d-amphetamine, morphine, naloxone, and drug combinations on visual discrimination in rats. Andrews JS; Holtzman SG Psychopharmacology (Berl); 1988; 94(2):172-7. PubMed ID: 3127842 [TBL] [Abstract][Full Text] [Related]
10. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists. Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087 [TBL] [Abstract][Full Text] [Related]
11. Discriminative stimulus properties of narcotic and non-narcotic drugs in rats trained to discriminate opiate kappa-receptor agonists. Shearman GT; Herz A Psychopharmacology (Berl); 1982; 78(1):63-6. PubMed ID: 6292982 [TBL] [Abstract][Full Text] [Related]
12. Discriminative effects of ethylketazocine in the rat: stereospecificity and antagonism by naloxone. Herling S; Shannon HE Life Sci; 1982 Nov 15-22; 31(20-21):2371-4. PubMed ID: 6131363 [TBL] [Abstract][Full Text] [Related]
13. mu-, delta- and kappa-opioid receptor agonists do not alter the discriminative stimulus effects of cocaine or d-amphetamine in rats. Woolfolk DR; Holtzman SG Drug Alcohol Depend; 1997 Dec; 48(3):209-20. PubMed ID: 9449020 [TBL] [Abstract][Full Text] [Related]
14. Opioid receptor ligands in the neonatal rat spinal cord: binding and in vitro depression of the nociceptive responses. James IF; Bettaney J; Perkins MN; Ketchum SB; Dray A Br J Pharmacol; 1990 Mar; 99(3):503-8. PubMed ID: 2158845 [TBL] [Abstract][Full Text] [Related]
15. Role of specific dopamine receptor subtypes in amphetamine discrimination. Smith FL; St John C; Yang TF; Lyness WH Psychopharmacology (Berl); 1989; 97(4):501-6. PubMed ID: 2567031 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological profile of various kappa-agonists at kappa-, mu- and delta-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the rat brain. Mulder AH; Burger DM; Wardeh G; Hogenboom F; Frankhuyzen AL Br J Pharmacol; 1991 Feb; 102(2):518-22. PubMed ID: 1673074 [TBL] [Abstract][Full Text] [Related]
17. D-amphetamine-like stimulus properties are produced by morphine injections into the ventral tegmental area but not into the nucleus accumbens. Druhan JP; Deschamps SE; Stewart J Behav Brain Res; 1993 Dec; 59(1-2):41-51. PubMed ID: 8155292 [TBL] [Abstract][Full Text] [Related]
18. The opioid agonist ethylketocyclazocine accentuates epinephrine-induced cardiac arrhythmias in the rat through an action in the brain. Rabkin SW Brain Res Bull; 1993; 31(3-4):427-32. PubMed ID: 8490741 [TBL] [Abstract][Full Text] [Related]
19. Generalization tests with intraventricularly applied pro-enkephalin B-derived peptides in rats trained to discriminate the opioid kappa receptor agonist ethylketocyclazocine. Shearman GT; Schulz R; Schiller PW; Herz A Psychopharmacology (Berl); 1985; 85(4):440-3. PubMed ID: 2862651 [TBL] [Abstract][Full Text] [Related]
20. Stimulus properties of d-amphetamine as compared to l-amphetamine. Schechter MD Eur J Pharmacol; 1978 Feb; 47(4):461-4. PubMed ID: 631192 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]